AMANDA BLISS: Open Payments
NPI 1225201288 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 10 payments from 7 companies in 2025. Trend: 2023 $806 · 2024 $671 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $102 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Tris Pharma Inc | 1 | $16 |
| Neos Therapeutics, LP | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, HETLIOZ, REXULTI, Dyanavel XR, Adzenys XR-ODT, LYBALVI.
Industry payments across KY — which companies pay providers there.
